comparemela.com

Latest Breaking News On - American society of hematology - Page 2 : comparemela.com

New armored CAR produces responses in patients whose cancers don t respond to current CAR T cell therapies

While CAR T cell therapy has revolutionized treatment for many blood cancers, including non-Hodgkin lymphoma (NHL), many patients who receive CAR T cell therapy do not experience a long-term remission. For those whose cancers return or become resistant after CAR T cell therapy, the prognosis is poor, with few options left.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.